South & Central America Needle-Free Injection Systems Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, Technology, Type, Usability, Site of Delivery, Application, and End User

Description

List of Tables

The South & Central America needle-free injection systems market is expected to grow from US$ 9.63 million in 2022 to US$ 24.84 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2022 to 2028.

New Technologies for Needle-Free Injection Systems to Bolster South & Central America Needle-Free Injection Systems Market during Forecast Period

Parenteral is often considered the default drug delivery route but is also an implausible process. Increasing the use of innovative technologies such as the use of artificial intelligence (AI), bar code identification (BI), telecare, and e-prescription can help clinicians and pharmacists in many ways by allowing the storage of patient planned proceedings and patient records and smoothening the vaccination process. As a result, many pharmaceutical manufacturers have embraced IT technology owing to the various benefits of automated IT and provide painless and effective drug delivery systems that can benefit the patients. For instance, Nemera developed a customizable platform-Safe'n'Sound. It is an add-on passive safety device for a prefilled syringe that is aimed at preventing potential needlestick injuries by stimulating a feature that automatically activates at the end of the injection and simplifies the injection process. Healthcare workers had to deal with various challenges due to NSIs, but the burden of these injuries has reduced with the changing technology. A few of the key players operating in the needle-free injection systems market such as Portal Instruments and PharmaJet are focusing on developing innovative products such as micro-array patches, digital needle free injectors, and wearable needle free insulin injectors to deal with issues related to outmoded challenges related to breakage, leakage, and needlestick prevention. Thus, with the surge in new technologies, the demand for needle-free injection systems are expected to grow during the forecast period.

Market Overview

The South & Central America needle-free injection systems market is segmented into Brazil, Argentina, and the Rest of South & Central America. The region held the smallest portion of the market in the global analysis. The market growth in the region is mainly driven by the growing adoption of needle-free injectors that provide ease-of-use and painless solutions, the availability of technologically advanced & user-friendly products, and the rise in the prevalence of infectious diseases. The market is likely to propel in the forecast period owing to the recent technological developments, which directly impacted the economy of Brazil. Moreover, the advantage of cost savings and improved work efficiencies are a few major attracting reasons for manufacturing companies to establish bases in South America.

South & Central America Needle-Free Injection Systems Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Needle-Free Injection Systems Market Segmentation

The South & Central America needle-free injection systems market is segmented on the basis of product, technology, type, durability, and country. Based on product, the South & Central America needle-free injection systems market is bifurcated into fillable needle-free injectors and prefilled needle-free injectors. The fillable needle-free injectors segment held a larger share of the market in 2022.

Based on technology, the South & Central America needle-free injection systems market is segmented into jet-based needle-free injectors, spring-based needle-free injectors, microarray patch injectors, and others. The jet-based needle-free injectors segment registered the largest share of the market in 2022.

Based on type, the South & Central America needle-free injection systems market is segmented into liquid-based needle-free injectors, projectile-based needle-free injectors, and powder-based needle-free injectors. The liquid-based needle-free injectors segment registered the largest share of the market in 2022.

Based on durability, the South & Central America needle-free injection systems market is bifurcated into disposable and reusable. The reusable segment held a larger share of the market in 2022.

Based on site of delivery, the South & Central America needle-free injection systems market is segmented into subcutaneous injectors, intramuscular injectors, and intradermal injectors. The subcutaneous injectors segment held the largest share of the market in 2022.

Based on application, the South & Central America needle-free injection systems market is segmented into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and others. The vaccine delivery segment held the largest share of the market in 2022.

Based on end user, the South & Central America needle-free injection systems market is segmented into hospitals, home care settings, research laboratories, pharmaceutical and biotechnology companies, and others. The hospitals segment held the largest share of the market in 2022.

Based on country, the South & Central America needle-free injection systems market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market in 2022.

Crossject, Ferring B.V., Medical International Technologies (MIT Canada) Inc, NuGen Medical Devices, and Zealand Pharma A/S are the leading companies operating in the needle-free injection systems market in South & Central America.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America needle-free injection systems market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America needle-free injection systems market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the needle-free injection systems market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00027753

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 SAM Needle Free Injection Systems Market - By Product
- 1.3.2 SAM Needle Free Injection Systems Market - By Technology
- 1.3.3 SAM Needle Free Injection Systems Market - By Type
- 1.3.4 SAM Needle Free Injection Systems Market - By Usability
- 1.3.5 SAM Needle Free Injection Systems Market - By Site of Delivery
- 1.3.6 SAM Needle Free Injection Systems Market - By Application
- 1.3.7 SAM Needle Free Injection Systems Market - By End User
- 1.3.8 SAM Needle Free Injection Systems Market - By Country

2. SAM Needle Free Injection Systems Market- Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. SAM Needle Free Injection Systems Market - Market Landscape

4.1 Overview
4.2 SAM PEST Analysis
4.3 Expert Opinion

5. SAM Needle Free Injection Systems Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Advantages of Using Self-injection Devices
5.2 Market Restraints
- 5.2.1 Higher Development Costs of Needle Free Injectors Compared to Conventional Injection Systems
5.3 Market Opportunities
- 5.3.1 Rising Demand for Vaccines and Biosimilars
5.4 Future Trends
- 5.4.1 Surge in New Technologies for Needle Free Injection System
5.5 Impact Analysis

6. Needle Free Injection System Market - SAM Analysis

6.1 SAM Needle Free Injection System Marker Revenue Forecast and Analysis

7. Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Product

7.1 Overview
7.2 SAM Needle Free Injection Systems Market, By Product 2022 & 2028 (%)
7.3 Fillable Needle Free Injectors
- 7.3.1 Overview
- 7.3.2 Fillable Needle Free Injectors: Revenue and Forecast to 2028 (US$ Thousand)
7.4 Prefilled Needle Free Injectors
- 7.4.1 Overview
- 7.4.2 Prefilled Needle Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)

8. Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Technology

8.1 Overview
8.2 SAM Needle Free Injection Systems Market, By Technology 2022 & 2028 (%)
8.3 Jet-Based Needle-Free Injectors
- 8.3.1 Overview
- 8.3.2 Jet-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8.4 Spring-Based Needle-Free Injectors
- 8.4.1 Overview
- 8.4.2 Spring-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8.5 Microarray Patch Injectors
- 8.5.1 Overview
- 8.5.2 Microarray Patch Injectors - Revenue and Forecast to 2028 (US$ Thousand)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others - Revenue and Forecast to 2028 (US$ Thousand)

9. Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Type

9.1 Overview
9.2 SAM Needle Free Injection Systems Market, By Type 2022 & 2028 (%)
9.3 Liquid-Based Needle-Free Injectors
- 9.3.1 Overview
- 9.3.2 Liquid-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
9.4 Projectile-Based Needle-Free Injectors
- 9.4.1 Overview
- 9.4.2 Projectile-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
9.5 Powder-Based Needle-Free Injectors
- 9.5.1 Overview
- 9.5.2 Powder-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)

10. SAM Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Usability

10.1 Overview
10.2 SAM Needle Free Injection Systems Market, By Usability 2022 & 2028 (%)
10.3 Disposable
- 10.3.1 Overview
- 10.3.2 Disposable - Revenue and Forecast to 2028 (US$ Thousand)
10.4 Reusable
- 10.4.1 Overview
- 10.4.2 Reusable - Revenue and Forecast to 2028 (US$ Thousand)

11. SAM Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Site of Delivery

11.1 Overview
11.2 SAM Needle Free Injection Systems Market, By Site of Delivery 2022 & 2028 (%)
11.3 Subcutaneous Injectors
- 11.3.1 Overview
- 11.3.2 Subcutaneous Injectors - Revenue and Forecast to 2028 (US$ Thousand)
11.4 Intramuscular Injectors
- 11.4.1 Overview
- 11.4.2 Intramuscular Injectors - Revenue and Forecast to 2028 (US$ Thousand)
11.5 Intradermal Injectors
- 11.5.1 Overview
- 11.5.2 Intradermal Injectors - Revenue and Forecast to 2028 (US$ Thousand)

12. SAM Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Application

12.1 Overview
12.2 SAM Needle Free Injection Systems Market, By Application 2022 & 2028 (%)
12.3 Vaccine Delivery
- 12.3.1 Overview
- 12.3.2 Vaccine Delivery - Market Revenue and Forecast to 2028 (US$ Thousand)
12.4 Insulin Delivery
- 12.4.1 Overview
- 12.4.2 Insulin Delivery - Market Revenue and Forecast to 2028 (US$ Thousand)
12.5 Pain Management
- 12.5.1 Overview
- 12.5.2 Pain Management - Market Revenue and Forecast to 2028 (US$ Thousand)
12.6 Oncology
- 12.6.1 Overview
- 12.6.2 Oncology - Market Revenue and Forecast to 2028 (US$ Thousand)
12.7 Dermatology
- 12.7.1 Overview
- 12.7.2 Dermatology - Market Revenue and Forecast to 2028 (US$ Thousand)
12.8 Others
- 12.8.1 Overview
- 12.8.2 Others - Market Revenue and Forecast to 2028 (US$ Thousand)

13. SAM Needle Free Injection Systems Market Analysis- By End User

13.1 Overview
13.2 SAM Needle Free Injection Systems Market, By End User 2022 & 2028 (%)
13.3 Pharmaceutical and Biotechnology Companies
- 13.3.1 Overview
- 13.3.2 Pharmaceutical and Biotechnology Companies - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.4 Hospitals
- 13.4.1 Overview
- 13.4.2 Hospitals - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.5 Research Laboratories
- 13.5.1 Overview
- 13.5.2 Research Laboratories - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.6 Home Care Settings
- 13.6.1 Overview
- 13.6.2 Home Care Settings - Market Revenue and Forecasts To 2028 (US$ Thousand)
13.7 Other End User
- 13.7.1 Overview
- 13.7.2 Other End User - Market Revenue and Forecasts To 2028 (US$ Thousand)

14. SAM Needle Free Injection Systems Market Revenue and Forecasts to 2028 - Country Analysis

14.1 Overview
- 14.1.1 SAM: Needle Free Injection System Market Share by Country - 2022 & 2028, (%)
  - 14.1.1.1 Brazil: Needle Free Injection System Market- Revenue and Forecasts To 2028 (USD Thousands)
    - 14.1.1.1.1 Brazil: Needle Free Injection System Market- Revenue and Forecasts To 2028 (USD Thousands)
    - 14.1.1.1.2 Brazil Needle Free Injection System Market, By Product - Revenue and Forecast to 2028 (U SD Thousands)
    - 14.1.1.1.3 Brazil Needle Free Injection System Market, by Technology, 2019-2028 (USD Thousands)
    - 14.1.1.1.4 Brazil Needle Free Injection System Market, by Type, 2019-2028 (USD Thousands)
    - 14.1.1.1.5 Brazil Needle Free Injection System Market, by Usability, 2019-2028 (USD Thousands)
    - 14.1.1.1.6 Brazil Needle Free Injection System Market, by Site of Delivery, 2019-2028 (USD Thousands)
    - 14.1.1.1.7 Brazil Needle Free Injection System Market, By Application - Revenue and Forecast to 2028 (USD Thousands)
    - 14.1.1.1.8 Brazil Needle Free Injection System Market, By End User - Revenue and Forecast to 2028 (USD Thousands)
  - 14.1.1.2 Argentina: Needle Free Injection System Market- Revenue and Forecasts To 2028 (USD Thousands)
    - 14.1.1.2.1 Argentina: Needle Free Injection System Market- Revenue and Forecasts To 2028 (USD Thousands)
    - 14.1.1.2.2 Argentina Needle Free Injection System Market, By Product - Revenue and Forecast to 2028 (USD Thousands)
    - 14.1.1.2.3 Argentina Needle Free Injection System Market, by Technology, 2019-2028 (USD Thousands)
    - 14.1.1.2.4 Argentina Needle Free Injection System Market, by Type, 2019-2028 (USD Thousands)
    - 14.1.1.2.5 Argentina Needle Free Injection System Market, by Usability, 2019-2028 (USD Thousands)
    - 14.1.1.2.6 Argentina Needle Free Injection System Market, by Site of Delivery, 2019-2028 (USD Thousands)
    - 14.1.1.2.7 Argentina Needle Free Injection System Market, By Application - Revenue and Forecast to 2028 (USD Thousands)
    - 14.1.1.2.8 Argentina Needle Free Injection System Market, By End User - Revenue and Forecast to 2028 (USD Thousands)
  - 14.1.1.3 Rest of SAM: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousands)
    - 14.1.1.3.1 Rest of SAM: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousands)
    - 14.1.1.3.2 Rest of SAM Needle Free Injection System Market, By Product - Revenue and Forecast to 2028 (USD Thousands)
    - 14.1.1.3.3 Rest of SAM Needle Free Injection System Market, by Technology, 2019-2028 (USD Thousands)
    - 14.1.1.3.4 Rest of SAM Needle Free Injection System Market, by Type, 2019-2028 (USD Thousands)
    - 14.1.1.3.5 Rest of SAM Needle Free Injection System Market, by Usability, 2019-2028 (USD Thousands)
    - 14.1.1.3.6 Rest of SAM Needle Free Injection System Market, by Site of Delivery, 2019-2028 (USD Thousands)
    - 14.1.1.3.7 Rest of SAM Needle Free Injection System Market, By Application - Revenue and Forecast to 2028 (USD Thousands)
    - 14.1.1.3.8 Rest of SAM Needle Free Injection System Market, By End User - Revenue and Forecast to 2028 (USD Thousands)

15. Needle-Free Injection System Market-Industry Landscape

15.1 Overview
15.2 Growth Strategies Done by the Companies in the Market (%)
15.3 Organic Developments
- 15.3.1 Overview
15.4 Inorganic Developments
- 15.4.1 Overview

16. Company Profiles

16.1 Crossject
- 16.1.1 Key Facts
- 16.1.2 Business Description
- 16.1.3 Products and Services
- 16.1.4 Financial Overview
- 16.1.5 SWOT Analysis
- 16.1.6 Key Developments
16.2 Zealand Pharma A/S
- 16.2.1 Key Facts
- 16.2.2 Business Description
- 16.2.3 Products and Services
- 16.2.4 Financial Overview
- 16.2.5 SWOT Analysis
- 16.2.6 Key Developments
16.3 Medical International Technologies (MIT Canada) Inc.
- 16.3.1 Key Facts
- 16.3.2 Business Description
- 16.3.3 Products and Services
- 16.3.4 Financial Overview
- 16.3.5 SWOT Analysis
- 16.3.6 Key Developments
16.4 NuGen Medical Devices
- 16.4.1 Key Facts
- 16.4.2 Business Description
- 16.4.3 Products and Services
- 16.4.4 Financial Overview
- 16.4.5 SWOT Analysis
- 16.4.6 Key Developments
16.5 Ferring B.V.
- 16.5.1 Key Facts
- 16.5.2 Business Description
- 16.5.3 Products and Services
- 16.5.4 Financial Overview
- 16.5.5 SWOT Analysis
- 16.5.6 Key Developments

17. Appendix

17.1 About The Insight Partners
17.2 Glossary of Terms